Manufacturers of the most accurate home tests on the market are excluded from the Biden administration's free COVID-19 test orders, relying instead on cheaper, less sensitive antigen tests.
Federal health officials justified spending millions on inexpensive rapid antigen tests to subsidize U.S. factory production, despite the funding primarily supporting manufacturers of less accurate diagnostics.
The FDA has authorized only four over-the-counter molecular test brands for COVID-19, recognized for their accuracy, yet remain expensive compared to the cheaper antigen alternatives.
The most accurate home tests available, authorized by the FDA, include Lucira, Aptitude Medical Systems, and 3EO Health, but at significantly higher price points than rapid antigen tests.
[
Collection
]
[
|
...
]